Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 6,493 | 16,052 | 4,965 | 3,596 | 0 |
| Gross Profit | 6,493 | 16,052 | 4,965 | 3,596 | N/A |
| Operating Expenses | 33,053 | 22,475 | 22,903 | 17,357 | 0 |
| Operating Income | -26,560 | -6,423 | -17,938 | -13,761 | N/A |
| Interest Expense | 0 | 1 | 1,158 | 2,741 | 0 |
| Other Income | -2,463 | -1,490 | -5,974 | -8,668 | 0 |
| Pre-tax Income | -29,023 | -7,914 | -25,070 | -25,170 | 0 |
| Net Income Continuous | -29,023 | -7,914 | -25,070 | -25,170 | N/A |
| Minority Interests | 111 | -42 | -113 | N/A | N/A |
| Net Income | $-29,134 | $-7,872 | $-24,957 | $-25,170 | $N/A |
| EPS Basic Total Ops | -1.47 | -1.79 | -5.96 | -6.03 | N/A |
| EPS Basic Continuous Ops | -1.46 | -1.79 | -5.99 | -6.03 | N/A |
| EPS Diluted Total Ops | -1.47 | -1.79 | -5.96 | -6.03 | N/A |
| EPS Diluted Continuous Ops | -1.46 | -1.79 | -5.99 | -6.03 | N/A |
| EBITDA(a) | $-26,325 | $-6,231 | $-17,807 | $-13,645 | $N/A |